Mahoney Lisa B, Rosen Rachel
Dr Mahoney is an instructor in pediatrics and Dr Rosen is an associate professor of pediatrics at Harvard Medical School in Boston, Massachusetts, as well as in the Motility and Functional Gastrointestinal Disorders Center and the Division of Gastroenterology, Hepatology and Nutrition at Boston Children's Hospital in Boston, Massachusetts.
Gastroenterol Hepatol (N Y). 2019 Dec;15(12):646-654.
The focus on a symptom-based definition for gastroesophageal reflux disease (GERD) in adults and children has contributed to widespread use of acid suppression medications in patients with so-called typical reflux symptoms to treat the possibility of acid-mediated disease. Diagnostic testing with upper endoscopy, esophageal biopsies, ambulatory reflux monitoring, and/or esophageal manometry is often pursued when patients do not respond optimally to these medications. By using information from this diagnostic testing, GERD has shifted from a single diagnosis to a phenotypic spectrum, and each phenotype has unique pathophysiologic mechanisms driving symptom perception. Understanding these mechanisms is important to tailor individualized treatment plans and guide therapeutic interventions. The aim of this article is to discuss the different reflux phenotypes, the utility of esophageal reflux testing, the mechanisms underlying symptoms, and the management strategies for each phenotype.
对成人和儿童胃食管反流病(GERD)基于症状的定义的关注,促使酸抑制药物在有所谓典型反流症状的患者中广泛使用,以治疗酸介导疾病的可能性。当患者对这些药物反应不佳时,通常会进行上消化道内镜检查、食管活检、动态反流监测和/或食管测压等诊断测试。通过利用这些诊断测试的信息,GERD已从单一诊断转变为表型谱,并且每种表型都有驱动症状感知的独特病理生理机制。了解这些机制对于制定个体化治疗方案和指导治疗干预很重要。本文的目的是讨论不同的反流表型、食管反流测试的效用、症状背后的机制以及每种表型的管理策略。